When A shares closed on December 29th, the Prev index fell-0.91% to close at 3597.0 points; the Shenzhen Composite Index fell-1.24% to close at 14653.82 points; and the gem index fell-1.4% to close at 3281.9 points.

The size index fluctuated lower throughout the day, the second line of yellow and white was obviously divided, the weighted plates such as liquor weakened, and the Shanghai Stock Exchange 50 led the two cities down. Medical devices, anti-viral concept stocks strengthened, Rong Jie Health, Le Xin Medical, Jiu'an Medical and other nearly 10 shares rose by the daily limit. Military stocks were stimulated by the news, aerospace power, China coastal defense seal board, China Shipbuilding Hanguang rose more than 15%. Liquor stocks fell sharply, Guizhou Moutai fell by more than 4%, Wuliangye fell by more than 5%, Gujing tribute wine, Yingjia tribute wine and alcoholic liquor fell by more than 7%. After the resumption of the card, Sanyang Horse rose the limit again to achieve 12 consecutive boards after opening the board. Up and down four or six stocks, the two cities today turnover of 997.3 billion yuan, 2021 annual turnover exceeded 2015, the highest annual total turnover of 254.5 trillion yuan, a record high.

　　Today's market situation is about like this, so which companies are sought after by the main force? Please look at the following table:

　　The financial position of the top three stocks is as follows:

According to the third quarterly report of Aikang Science and Technology 2021, the company's main income was 2.027 billion yuan, down 16.7% from the same period last year; the net profit was-120.0043 million yuan, down 1105.97% from the same period last year; and deducting non-net profit from-243.9868 million yuan, down 969.7% from the same period last year. In the third quarter of 2021, the company's main revenue in a single quarter was 760 million yuan, up 9.44% from the same period last year. The net profit of returning to the mother in a single quarter was-53.2854 million yuan, down 254.42% from the same period last year; the non-net profit in a single quarter was-75.3064 million yuan, down 108.93% from the same period last year; the debt ratio was 54.06%, the investment income was 175 million yuan, the financial expenses was 184 million yuan, and the gross profit margin was 3.46%.

According to the third quarterly report of China Satellite 2021, the company's main income was 4.256 billion yuan, down 2.48% from the same period last year; the net profit was 214 million yuan, down 10.4% from the same period last year; and the non-net profit was 203 million yuan, down 10.28% from the same period last year. Among them, in the third quarter of 2021, the company's main income in a single quarter was 1.197 billion yuan, down 26.61% from the same period last year; and the net profit in a single quarter was 60.0964 million yuan, down 32.84% from the same period last year. The non-net profit in a single quarter was 55.9222 million yuan, down 34.75% from the same period last year; the debt ratio was 45.31%, the investment income was 588500 yuan, the financial expenses were-5.367 million yuan, and the gross profit margin was 14.76%.

According to the third quarterly report of Jiuan Medical in 2021, the company's main income was 790 million yuan, down 50.82% from the same period last year; the net profit was 50.128 million yuan, down 86.19% from the same period last year; and the non-net profit was-24.775 million yuan, down 106.89% from the same period last year. Among them, in the third quarter of 2021, the company's main income in a single quarter was 221 million yuan, down 60.93% from the same period last year; net profit in a single quarter was-4.649 million yuan, down 104.41% from the same period last year The non-net profit in a single quarter was-19.9876 million yuan, down 119.31% from the same period last year; the debt ratio was 24.2%, the investment income was 52.2648 million yuan, the financial expenses were 8.7241 million yuan, and the gross profit margin was 37.35%.